Small-Molecule Drug Start-Ups
This article was originally published in Start Up
Executive Summary
Companies pursuing small-molecule drugs are by far the most popular of the start-ups in biopharmaceuticals. But the biggest opportunity in the business is still up for grabs: the industrialization of medicinal chemistry.